These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer. Greven KM; Williams DW; Keyes JW; McGuirt WF; Harkness BA; Watson NE; Raben M; Frazier LC; Geisinger KR; Cappellari JO Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):841-5. PubMed ID: 8040032 [TBL] [Abstract][Full Text] [Related]
4. Differentiation between recurrent brain tumour and post-radiation necrosis: the value of 201Tl SPET versus 18F-FDG PET using a dual-headed coincidence camera--a pilot study. Stokkel M; Stevens H; Taphoorn M; Van Rijk P Nucl Med Commun; 1999 May; 20(5):411-7. PubMed ID: 10404525 [TBL] [Abstract][Full Text] [Related]
5. Can positron emission tomography distinguish tumor recurrence from irradiation sequelae in patients treated for larynx cancer? Greven KM; Williams DW; Keyes JW; McGuirt WF; Watson NE; Case LD Cancer J Sci Am; 1997; 3(6):353-7. PubMed ID: 9403048 [TBL] [Abstract][Full Text] [Related]
6. Differentiation of cerebral radiation necrosis from tumor recurrence by [18F]FDG and 82Rb positron emission tomography. Doyle WK; Budinger TF; Valk PE; Levin VA; Gutin PH J Comput Assist Tomogr; 1987; 11(4):563-70. PubMed ID: 3496366 [TBL] [Abstract][Full Text] [Related]
7. Improved detection of recurrent laryngeal tumor after radiotherapy using (18)FDG-PET as initial method. Brouwer J; de Bree R; Comans EF; Akarriou M; Langendijk JA; Castelijns JA; Hoekstra OS; Leemans CR Radiother Oncol; 2008 May; 87(2):217-20. PubMed ID: 18329117 [TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and treatment of laryngeal radionecrosis]. Morales C; del Valle A; Rubio A; Mazón A; Rama J Acta Otorrinolaringol Esp; 1997 May; 48(4):295-8. PubMed ID: 9376141 [TBL] [Abstract][Full Text] [Related]
10. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies. Di Chiro G; Oldfield E; Wright DC; De Michele D; Katz DA; Patronas NJ; Doppman JL; Larson SM; Ito M; Kufta CV AJR Am J Roentgenol; 1988 Jan; 150(1):189-97. PubMed ID: 3257119 [TBL] [Abstract][Full Text] [Related]
11. [18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancer. Been LB; Hoekstra HJ; Suurmeijer AJ; Jager PL; van der Laan BF; Elsinga PH Oral Oncol; 2009 Dec; 45(12):e211-5. PubMed ID: 19692292 [TBL] [Abstract][Full Text] [Related]
12. Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Patronas NJ; Di Chiro G; Brooks RA; DeLaPaz RL; Kornblith PL; Smith BH; Rizzoli HV; Kessler RM; Manning RG; Channing M; Wolf AP; O'Connor CM Radiology; 1982 Sep; 144(4):885-9. PubMed ID: 6981123 [TBL] [Abstract][Full Text] [Related]
13. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography. Glantz MJ; Hoffman JM; Coleman RE; Friedman AH; Hanson MW; Burger PC; Herndon JE; Meisler WJ; Schold SC Ann Neurol; 1991 Apr; 29(4):347-55. PubMed ID: 1929205 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of dual-head 18F-fluorodeoxyglucose PET for the detection of recurrent laryngeal cancer. Bongers V; Hobbelink MG; van Rijk PP; Hordijk GJ Cancer Biother Radiopharm; 2002 Jun; 17(3):303-6. PubMed ID: 12136522 [TBL] [Abstract][Full Text] [Related]
15. Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression? Belohlávek O; Simonová G; Kantorová I; Novotný J; Liscák R Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):96-100. PubMed ID: 12483415 [TBL] [Abstract][Full Text] [Related]
16. Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury. Ogawa T; Kanno I; Shishido F; Inugami A; Higano S; Fujita H; Murakami M; Uemura K; Yasui N; Mineura K Acta Radiol; 1991 May; 32(3):197-202. PubMed ID: 2064862 [TBL] [Abstract][Full Text] [Related]
17. PET versus SPECT in distinguishing radiation necrosis from tumor recurrence in the brain. Buchpiguel CA; Alavi JB; Alavi A; Kenyon LC J Nucl Med; 1995 Jan; 36(1):159-64. PubMed ID: 7799071 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of an (18)F-FDG-PET based strategy to optimize the diagnostic trajectory of suspected recurrent laryngeal carcinoma after radiotherapy: The RELAPS multicenter randomized trial. de Bree R; van der Putten L; van Tinteren H; Wedman J; Oyen WJ; Janssen LM; van den Brekel MW; Comans EF; Pruim J; Takes RP; Hobbelink MG; Valdés Olmos R; van der Laan BF; Boers M; Hoekstra OS; Leemans CR Radiother Oncol; 2016 Feb; 118(2):251-6. PubMed ID: 26477395 [TBL] [Abstract][Full Text] [Related]
19. Primary and recurrent early stage laryngeal cancer: preliminary results of 2-[fluorine 18]fluoro-2-deoxy-D-glucose PET imaging. Lowe VJ; Kim H; Boyd JH; Eisenbeis JF; Dunphy FR; Fletcher JW Radiology; 1999 Sep; 212(3):799-802. PubMed ID: 10478249 [TBL] [Abstract][Full Text] [Related]
20. Fluorine-18-FDG detection of laryngeal cancer postradiotherapy using dual-head coincidence imaging. Stokkel MP; Terhaard CH; Mertens IJ; Hordijk GJ; van Rijk PP J Nucl Med; 1998 Aug; 39(8):1385-7. PubMed ID: 9708513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]